Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infection

Clinical Microbiology and Infection

Volumn 19, Issue 5, 2013, Pages

  Frange, P ^a,b   Meyer, L ^c   Ghosn, J ^a,d   Deveau, C ^c   Goujard, C ^c,e   Duvivier, C ^b   Tubiana, R ^f   Rouzioux, C ^a,b   Chaix, M L ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSERM   (France)

^d HÔTEL DIEU   (France)

^e BICÊTRE HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CCR5; CXCR4; HIV 1; Primary infection; Transmission clusters

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VIRUS STRAIN; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84876344448     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12127     Document Type: Article

References (15)

1. Keele BF, Giorgi EE, Salazar-Gonzalez JF et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008; 105: 7552-7557.
2. Frange P, Galimand J, Goujard C et al. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO cohort study. J Antimicrob Chemother 2009; 64: 135-141.
3. Frange P, Chaix ML, Raymond S et al. Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B infection. J Clin Microbiol 2010; 48: 3487-3491.
4. Long EM, Rainwater SM, Lavreys L, Mandaliya K, Overbaugh J. HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. AIDS Res Hum Retroviruses 2002; 18: 567-576.
5. Margolis L, Shattock R. Selective transmission of CCR5-utilizing HIV-1: the "gatekeeper" problem resolved? Nat Rev Microbiol 2006; 4: 312-317.
6. Grivel JC, Shattock RJ, Margolis LB. Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J Transl Med 2011; 9 (Suppl 1): S6.
7. Schuitemaker H, van't Wout AB, Lusso P. Clinical significance of HIV-1 coreceptor usage. J Transl Med 2011; 9 (Suppl 1): S5.
8. Chalmet K, Dauwe K, Foquet L et al. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission. J Infect Dis 2012; 205: 174-184.
9. Frange P, Meyer L, Deveau C et al. Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency. PLoS ONE 2012; 7: e31695.
10. Goujard C, Bonarek M, Meyer L et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006; 42: 709-715.
11. Raymond S, Delobel P, Mavigner M et al. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression. AIDS 2010; 24: 2305-2312.
12. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
13. Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA 2004; 101: 11030-11035.
14. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599.
15. Hue S, Clewley JP, Cane PA, Pillay D. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 2004; 18: 719-728.